Literature DB >> 10993770

Adverse effects of constitutively active alpha(1B)-adrenergic receptors after pressure overload in mouse hearts.

B H Wang1, X J Du, D J Autelitano, C A Milano, E A Woodcock.   

Abstract

Cardiac hypertrophy and function were studied 6 wk after constriction of the thoracic aorta (TAC) in transgenic (TG) mice expressing constitutively active mutant alpha(1B)-adrenergic receptors (ARs) in the heart. Hearts from sham-operated TG animals and nontransgenic littermates (WT) were similar in size, but hearts from TAC/TG mice were larger than those from TAC/WT mice, and atrial natriuretic peptide mRNA expression was also higher. Lung weight was markedly increased in TAC/TG animals, and the incidence of left atrial thrombus formation was significantly higher. Ventricular contractility in anesthetized animals, although it was increased in TAC/WT hearts, was unchanged in TAC/TG hearts, implying cardiac decompensation and progression to failure in TG mice. There was no increase in alpha(1A)-AR mRNA expression in TAC/WT hearts, and expression was significantly reduced in TAC/TG hearts. These findings show that cardiac expression of constitutively actively mutant alpha(1B)-ARs is detrimental in terms of hypertrophy and cardiac function after pressure overload and that increased alpha(1A)-AR mRNA expression is not a feature of the hypertrophic response in this murine model.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10993770     DOI: 10.1152/ajpheart.2000.279.3.H1079

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  11 in total

1.  Label-Free Dynamic Mass Redistribution Reveals Low-Density, Prosurvival α1B-Adrenergic Receptors in Human SW480 Colon Carcinoma Cells.

Authors:  Dorathy-Ann Harris; Ji-Min Park; Kyung-Soon Lee; Cong Xu; Nephi Stella; Chris Hague
Journal:  J Pharmacol Exp Ther       Date:  2017-02-14       Impact factor: 4.030

Review 2.  Adrenoceptor regulation of the mechanistic target of rapamycin in muscle and adipose tissue.

Authors:  Ling Yeong Chia; Bronwyn A Evans; Saori Mukaida; Tore Bengtsson; Dana S Hutchinson; Masaaki Sato
Journal:  Br J Pharmacol       Date:  2019-04-07       Impact factor: 8.739

Review 3.  Alpha-1-adrenergic receptors: targets for agonist drugs to treat heart failure.

Authors:  Brian C Jensen; Timothy D O'Connell; Paul C Simpson
Journal:  J Mol Cell Cardiol       Date:  2010-11-28       Impact factor: 5.000

Review 4.  Cardiac and neuroprotection regulated by α(1)-adrenergic receptor subtypes.

Authors:  Dianne M Perez; Van A Doze
Journal:  J Recept Signal Transduct Res       Date:  2011-02-21       Impact factor: 2.092

5.  No contribution of IP3-R(2) to disease phenotype in models of dilated cardiomyopathy or pressure overload hypertrophy.

Authors:  Nicola Cooley; Kunfu Ouyang; Julie R McMullen; Helen Kiriazis; Farah Sheikh; Wei Wu; Yongxin Mu; Xiao-Jun Du; Ju Chen; Elizabeth A Woodcock
Journal:  Circ Heart Fail       Date:  2012-12-20       Impact factor: 8.790

Review 6.  Cardiac alpha1-adrenergic receptors: novel aspects of expression, signaling mechanisms, physiologic function, and clinical importance.

Authors:  Timothy D O'Connell; Brian C Jensen; Anthony J Baker; Paul C Simpson
Journal:  Pharmacol Rev       Date:  2013-12-24       Impact factor: 25.468

7.  α₁A-adrenergic receptors regulate cardiac hypertrophy in vivo through interleukin-6 secretion.

Authors:  Robert S Papay; Ting Shi; Michael T Piascik; Sathyamangla V Naga Prasad; Dianne M Perez
Journal:  Mol Pharmacol       Date:  2013-02-12       Impact factor: 4.436

Review 8.  Adrenergic signaling in heart failure: a balance of toxic and protective effects.

Authors:  Anthony J Baker
Journal:  Pflugers Arch       Date:  2014-03-14       Impact factor: 3.657

9.  α1A-Adrenergic receptor prevents cardiac ischemic damage through PKCδ/GLUT1/4-mediated glucose uptake.

Authors:  Ting Shi; Robert S Papay; Dianne M Perez
Journal:  J Recept Signal Transduct Res       Date:  2015-09-29       Impact factor: 2.092

10.  The IP3 receptor regulates cardiac hypertrophy in response to select stimuli.

Authors:  Hiroyuki Nakayama; Ilona Bodi; Marjorie Maillet; Jaime DeSantiago; Timothy L Domeier; Katsuhiko Mikoshiba; John N Lorenz; Lothar A Blatter; Donald M Bers; Jeffery D Molkentin
Journal:  Circ Res       Date:  2010-07-08       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.